Balchem Corp (BCPC)
123.49
-3.78
(-2.97%)
USD |
NASDAQ |
Mar 22, 16:00
123.49
0.00 (0.00%)
After-Hours: 18:26
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 3.973B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -8.56% |
| Valuation | |
| PE Ratio | 38.00 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 4.244 |
| Price to Book Value | 4.234 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.71 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.4695 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 36.70% |
News
Headline
Wire
Time (ET)
MT Newswires
02/27 09:10
MT Newswires
02/24 07:01
MT Newswires
02/24 07:01
Globe Newswire
02/24 07:00
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 04/28/2023* | -- | Results | Q1 2023 | -- | 0.93 | -- | |
| 04/28/2023* | 11:00 EST | Earnings Call | Q1 2023 | -- | -- | -- | |
| 02/24/2023 | -- | Results | Q4 2022 | 0.94 | 0.91 | 3.30% | |
| 02/24/2023 | 11:00 EST | Earnings Call | Q4 2022 | -- | -- | -- | |
| 11/04/2022 | -- | Results | Q3 2022 | 1.00 | 1.03 | -2.91% | |
| 11/04/2022 | 11:00 EST | Earnings Call | Q3 2022 | -- | -- | -- | |
| 07/29/2022 | 11:00 EST | Earnings Call | Q2 2022 | -- | -- | -- | |
| 07/29/2022 | -- | Results | Q2 2022 | 1.07 | 1.00 | 7.00% |
*Estimated Date/Time
Earnings
Profile
Edit
| Balchem Corp is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, agricultural, and medical sterilization industries. The segments include 1) Human Nutrition and Health segment provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications. 2) Animal Nutrition and Health segment provide nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride. 3) Specialty Products segment includes re-packaging and distributing a number of performance gases and chemicals for various uses, notably ethylene oxide, propylene oxide, and ammonia. |
| URL | https://www.balchem.com |
| Investor Relations URL | https://balchem.com/our-company/investor-relations |
| HQ State/Province | New Jersey |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | Apr. 28, 2023 (est.) |
| Last Earnings Release | Feb. 24, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 23, 2022 |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | 0.71 |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.3979 |
| Yield to Sector | 0.1483 |
| Yield to Industry | 0.1858 |
| Last Dividend Amt. | 0.71 |
| Dividend Frequency | Annually |
| Last Ex-Dividend Date | Dec. 23, 2022 |
| Yield (TTM) | 0.57% |
| Forward Yield | 0.56% |
| Payout Ratio | 19.66% |
| Cash Payout Ratio | 23.47% |
| Consistent Payer (5Y) |
|
| Consistent Growth (5Y) |
|
Risk
Total Returns Comparison
Annual Total Returns Versus Peers
As of March 21, 2023.
Fundamentals
| Revenue (TTM) | 942.36M |
| Total Expenses (TTM) | 797.17M |
| Net Income (TTM) | 105.37M |
| Total Assets (Quarterly) | 1.625B |
| Total Liabilities (Quarterly) | 686.23M |
| Shareholders Equity (Quarterly) | 938.28M |
| Cash from Operations (TTM) | 138.54M |
| Cash from Investing (TTM) | -416.01M |
| Cash from Financing (TTM) | 246.68M |
Ratings
Profile
Edit
| Balchem Corp is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, agricultural, and medical sterilization industries. The segments include 1) Human Nutrition and Health segment provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications. 2) Animal Nutrition and Health segment provide nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride. 3) Specialty Products segment includes re-packaging and distributing a number of performance gases and chemicals for various uses, notably ethylene oxide, propylene oxide, and ammonia. |
| URL | https://www.balchem.com |
| Investor Relations URL | https://balchem.com/our-company/investor-relations |
| HQ State/Province | New Jersey |
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Equity Style | Small Cap/Growth |
| Next Earnings Release | Apr. 28, 2023 (est.) |
| Last Earnings Release | Feb. 24, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Dec. 23, 2022 |
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Top Fund Holders
| Symbol | Dollars Invested | % Weight |
|---|---|---|
| WGMCX | 34.72M USD | 2.65% |
| WIGRX | 69.69M USD | 2.58% |
| NWKBX | 34.93M USD | 2.51% |
| CCASX | 83.42M USD | 2.47% |
| SMDV | 8.566M USD | 1.09% |
| IJT | 45.66M USD | 0.92% |
| SLYG | 20.91M USD | 0.90% |
| IJR | 316.46M USD | 0.47% |
| SPSM | 22.32M USD | 0.46% |
| VTSIX | 38.61M USD | 0.45% |
| VSMSX | 19.48M USD | 0.45% |
| VIOO | 19.48M USD | 0.45% |
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Nasdaq | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| BCPC Tweets |